Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 19;50(3):166. doi: 10.3892/or.2023.8603

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Lukoseviciute et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 1. — WST-1 viability assay in NB cell lines following treatment with CDK4/6 inhibitor PD and PI3K inhibitor BYL. Viability of SK-N-AS treated with (A) PD, BYL (B) and combination of PD and BYL (C), viability of SK-N-BE(2)-C treated with PD (D), BYL (E) and combination of PD and BYL (F), viability of SK-N-DZ treated with PD (G), BYL (H) and combination of PD and BYL (I), viability of SK-N-FI treated with PD (J), BYL (K) and combination of PD and BYL (L) and viability of SK-N-SH treated with PD (M), BYL (N) and combination of PD and BYL (O) was measured by absorbance. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 treatments compared with PBS each time point. NB, neuroblastoma; PD, PD-0332991; BYL, BYL719.